Clinical Trials on Hematological Malignancies in New Zealand
Total 2824 results
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Smart Immune SASRecruitingHematological MalignanciesUnited States
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
Esanex Inc.Completed
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, Japan, Taiwan, Australia, Germany, China
-
Gilead SciencesTerminatedHematological MalignanciesUnited States, United Kingdom
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesUnited States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Effector TherapeuticsTerminated
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
IncuronTerminatedHematological MalignanciesUnited States
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
Vanda PharmaceuticalsUnknownRelapsed or Refractory Hematologic MalignanciesUnited States
-
Precision BioSciences, Inc.RecruitingHematologic Malignancy | CD19 Expressing MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingHematologic MalignanciesUnited States
-
Synta Pharmaceuticals Corp.CompletedLymphoma | Leukemia | Hematological Malignancies | Metastatic or Unresectable Solid TumorsUnited States
-
NYU Langone HealthActive, not recruitingHematologic MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
University of RochesterRecruitingHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedHematologic MalignanciesUnited States
-
University Hospital of CologneRadboud University Medical CenterCompletedInvasive AspergillosisGermany, Netherlands
-
Kah Poh LohWithdrawn
-
NYU Langone HealthTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Infinity Pharmaceuticals, Inc.Terminated
-
Yale UniversityHospira, now a wholly owned subsidiary of PfizerCompleted
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States
-
SecuraBioTerminatedHematologic MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingSolid Tumor | Hematologic Malignancy | Solid Tumor, Adult | Solid CarcinomaUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingCancer | Hematologic Malignancy | Blood Cancer | Tumor, SolidUnited States
-
Roswell Park Cancer InstituteRecruitingHematopoietic and Lymphoid System NeoplasmUnited States
-
Matthew DallosBristol-Myers SquibbTerminatedSolid Tumor | Sars-CoV2 | Hematological MalignancyUnited States
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
Monash UniversityRecruitingHypogammaglobulinemia | Haematological MalignancyAustralia
-
Weill Medical College of Cornell UniversityActive, not recruitingHematologic Malignancy | Bone Marrow TransplantUnited States
-
Fate TherapeuticsTerminatedHematologic MalignanciesUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Hackensack Meridian Health; Lombardi Comprehensive...CompletedStem Cell Transplantation | Hematologic MalignancyUnited States
-
Hutchison Medipharma LimitedIqvia Pty LtdUnknownHematologic MalignanciesAustralia
-
Pharmacosmos A/SCompletedNon-myeloid Malignancies | Chemotherapy Induced AnaemiaIndia
-
Weill Medical College of Cornell UniversityActive, not recruitingTargeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord TransplantationHematologic MalignanciesUnited States
-
Novartis PharmaceuticalsTerminatedSolid Tumor | Hematologic MalignanciesUnited States